Summary & Overview
HCPCS M1057: Antiplatelet Therapy Not Used, Reason Not Given
HCPCS Level II code M1057 denotes that aspirin or another antiplatelet therapy was not used and no reason was specified. This documentation code matters nationally because antiplatelet use is a common element of cardiovascular and perioperative care; recording the absence of therapy has implications for clinical records, quality measurement, and claims adjudication. The code helps payers and providers track instances where expected therapy was omitted without a documented rationale.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, how it is typically used in inpatient and outpatient settings, and what documentation this code represents. The publication summarizes common billing modifiers associated with medication and procedure reporting, notes that specific related taxonomies and ICD-10 pairings are not provided in the input, and highlights areas where payers commonly review such claims for medical necessity and coding completeness.
The report provides national-level benchmarks and policy context where available, explains typical service lines and sites of service for M1057, and outlines gaps in the input data where additional payer- or facility-specific guidance may be required. Data not available in the input is identified transparently.
Billing Code Overview
HCPCS Level II code M1057 indicates aspirin or another antiplatelet therapy not used, reason not given. This code documents that an antiplatelet agent (for example, aspirin) was not administered or prescribed, without a specified reason recorded.
Service type: Medication administration / pharmacologic management (antiplatelet therapy not given)
Typical site of service: Inpatient or outpatient clinical settings where antiplatelet therapy would be considered, such as hospitals, emergency departments, ambulatory clinics, or procedural units.
Clinical & Coding Specifications
Clinical Context
A 72-year-old male with a history of recent ischemic stroke is evaluated on admission to a short-stay observation unit. The care team documents that antiplatelet therapy such as aspirin is not administered during the inpatient/observation stay and the reason for omission is not recorded in the medical record. Typical workflow includes initial neurologic assessment, medication reconciliation, documentation of secondary stroke prevention plan, and nursing medication administration. A clinician or coder reviewing the chart may assign HCPCS Level II code M1057 when an antiplatelet agent was not used and no documented reason explains the omission. Documentation review often includes reconciliation of home medications, review of contraindications (active bleeding, recent surgery), and cross-checking orders and MAR (medication administration record) to confirm absence of antiplatelet therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work or complexity related to medication management or documentation significantly exceeds typical service for the encounter. |
23 |